Diabetes drug tirzepatide linked to more significant weight loss than semaglutide Diabetes drug tirzepatide is associated with significantly more weight loss than semaglutide, according to a new analysis published in JAMA Internal Medicine .[1] A bit of background about tirzepatide and semaglutide The studys authors noted that tirzepatide and semaglutide represent significant progress compared to previous weight reduction medications
The Phase 3 TRIUMPH-4 trial (NCT05869903) enrolled adults with obesity and knee osteoarthritis
SUPPORT METABOLIC HARMONY: Feel lighter after meals, free from the discomfort of bloating, so you can stay focused and productive
The current dietary guidelines for Americans recommend a dietary pattern consisting primarily of nutrient-dense foods (like fruits and vegetables, whole grains, lean proteins, and low-fat dairy products) and limiting added sugar, sodium, and saturated fat
Interaction between NLRP3 and NEK7 is affected by palmitoylation